Pathway and Urgent caRe of Dyspneic Patient at the Emergency Department in LorrainE District (PURPLE) (PURPLE)

October 9, 2017 updated by: Central Hospital, Nancy, France

Pathway and Urgent caRe of Dyspneic Patient at the Emergency Department in LorrainE District

This is an observational prospective multicenter study of patients admitted for acute dyspnea in an emergency department of the participating centers in the Lorraine district.

The primary objective is to assess the outcome of this population according to the cause of acute dyspnea as well as identify the predictors of this outcome, both overall and according to each acute dyspnea cause.

Study Overview

Status

Recruiting

Conditions

Detailed Description

This observational prospective multicenter study will be conducted using data from electronic medical records, acquired as part of usual care, in patients admitted for acute dyspnea in the emergency department. Clinical, treatment, laboratory and imaging data acquired during the hospitalization (in the emergency department and in the department that admitted the patients following the emergency department stay) will be collected.

Vital status will be recorded at 30 days and 1 year post-admission.

Study Type

Observational

Enrollment (Anticipated)

75000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Lorraine
      • Forbach, Lorraine, France, 57604
        • Recruiting
        • CH Marie-Madeleine FORBACH - Service des Urgences
        • Contact:
          • Caroline HLADNIK, MD
        • Principal Investigator:
          • Caroline HLADNIK, MD
      • Lunéville, Lorraine, France, 54 301
        • Recruiting
        • CH LUNEVILLE - Service des Urgences
        • Contact:
          • Julie THISSE, MD
        • Principal Investigator:
          • Julie THISSE, MD
      • Metz, Lorraine, France, 57085
        • Recruiting
        • CHR METZ-THIONVILLE- Hôpital de Mercy- Service des Urgences
        • Contact:
          • Elies ANDRE, MD
        • Principal Investigator:
          • Elies ANDRE, MD
      • Nancy, Lorraine, France, 54000
        • Recruiting
        • CHRU Nancy - Service des Urgences
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Adrien BASSAND, MD
      • Pont-à-Mousson, Lorraine, France, 54 701
        • Recruiting
        • CH PONT A MOUSSON- Service des Urgences
        • Contact:
          • Alexandre GROSJEAN, MD
        • Principal Investigator:
          • Alexandre GROSJEAN, MD
      • Remiremont, Lorraine, France, 88204
        • Recruiting
        • CH REMIREMONT - Service des Urgences
        • Contact:
          • Marie BREFFA, MD
        • Principal Investigator:
          • Marie BREFFA, MD
      • Saint-Dié-des-Vosges, Lorraine, France, 88100
        • Recruiting
        • CH SAINT-DIE-DES-VOSGES - Service des Urgences
        • Contact:
          • Patrice THIRION, MD
        • Principal Investigator:
          • Patrice THIRION, MD
      • Thionville, Lorraine, France, 57100
        • Recruiting
        • CHR METZ-THIONVILLE- Hôpital Bel-Air- Service des Urgences
        • Contact:
          • Phillippe SATTONNET, MD
        • Principal Investigator:
          • Phillippe SATTONNET, MD
      • Épinal, Lorraine, France, 88021
        • Recruiting
        • CH EPINAL - Service des Urgences
        • Contact:
          • Céline HOMEL, MD
        • Principal Investigator:
          • Céline HOMEL, MD
        • Sub-Investigator:
          • Jean-Dominique RISSER, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with acute dyspnea and treated in an emergency department of the participating centers in the Lorraine district.

Description

Inclusion Criteria:

  • Men or women > or = 18 years.
  • Patients with acute dyspnea admitted for acute dyspnea in the emergency department.
  • Patient informed.

Exclusion Criteria:

  • Cardiorespiratory arrest.
  • Patient having expressed his or her opposition.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients admitted for acute dyspnea
Patients admitted for acute dyspnea in the emergency department

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
All cause mortality
Time Frame: From emergency admission for acute dyspnea up until 1 year
From emergency admission for acute dyspnea up until 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographic data
Time Frame: through hospital stay, an average of 10 days
through hospital stay, an average of 10 days
Clinical data
Time Frame: through hospital stay, an average of 10 days
through hospital stay, an average of 10 days
Treatment data
Time Frame: through hospital stay, an average of 10 days
through hospital stay, an average of 10 days
Laboratory data
Time Frame: through hospital stay, an average of 10 days
through hospital stay, an average of 10 days
Imaging data
Time Frame: through hospital stay, an average of 10 days
through hospital stay, an average of 10 days
Duration of hospitalization
Time Frame: At final discharge, an average of 10 days after admission
including emergency stay and conventional hospitalization
At final discharge, an average of 10 days after admission
Initial diagnosis in the emergency department
Time Frame: At admission
At admission
Final diagnosis of the initial hospitalization stay
Time Frame: At final discharge, an average of 10 days after admission
At final discharge, an average of 10 days after admission
Brain Natriuretic Peptide
Time Frame: Through hospital stay, an average of 10 days
Through hospital stay, an average of 10 days
Estimated glomerular function rate
Time Frame: Through hospital stay, an average of 10 days
Through hospital stay, an average of 10 days
Estimated plasma volume
Time Frame: Through hospital stay, an average of 10 days
Through hospital stay, an average of 10 days
Liver biological biomarkers
Time Frame: Through hospital stay, an average of 10 days
Through hospital stay, an average of 10 days
Urea
Time Frame: Through hospital stay, an average of 10 days
Through hospital stay, an average of 10 days
Use of non-invasive ventilation
Time Frame: Through hospital stay, an average of 10 days
Through hospital stay, an average of 10 days
Time of use of non-invasive ventilation
Time Frame: Through hospital stay, an average of 10 days
Through hospital stay, an average of 10 days
Use of diuretics
Time Frame: Through hospital stay, an average of 10 days
Through hospital stay, an average of 10 days
Time of use of diuretics
Time Frame: Through hospital stay, an average of 10 days
Through hospital stay, an average of 10 days
Use of nitrates
Time Frame: Through hospital stay, an average of 10 days
Through hospital stay, an average of 10 days
Time of use of nitrates
Time Frame: Through hospital stay, an average of 10 days
Through hospital stay, an average of 10 days
Department type admitting the patient following emergency management
Time Frame: Through hospital stay, an average of 10 days
intensive care unit, cardiology, cardiac intensive care unit, other ...
Through hospital stay, an average of 10 days
All cause in-hospital mortality
Time Frame: At final discharge, an average of 10 days after admission
At final discharge, an average of 10 days after admission

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tahar CHOUIHED, MD, Central Hospital, Nancy, France
  • Principal Investigator: Nicolas GIRERD, MD,PhD, Central Hospital, Nancy, France

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 5, 2017

Primary Completion (Anticipated)

October 1, 2023

Study Completion (Anticipated)

October 1, 2023

Study Registration Dates

First Submitted

May 29, 2017

First Submitted That Met QC Criteria

June 20, 2017

First Posted (Actual)

June 21, 2017

Study Record Updates

Last Update Posted (Actual)

October 10, 2017

Last Update Submitted That Met QC Criteria

October 9, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Dyspnea

3
Subscribe